Unibest 优贝德
← Back to patent-cliff list

Bremelanotide

Tier C — Watch / trade

Bremelanotide

Amag Pharmaceuticals Inc
Originator
2019
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type

TargetsMCRs

BrandVyleesi、Rekynda

Indications (approved)心理性性功能障碍

Regional status

US
批准上市
2019-06-21
EU
-
China
无进展
2020-10-28
Japan
-

Synthetic routes & intermediates4 routes

Originator routes × 1Optimised (non-patent) × 3Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 9 · Total yield /
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
BREM-001--
BREM-002--
BREM-003--
BREM-004--
BREM-005--
BREM-006--
BREM-007--
BREM-008--
BREM-009--
Bremelanotide189691-06-3-
OptimisedRoute 2Steps 9 · Total yield 29.47 mg
Synthetic routes & intermediates Route 2
CodeCAS No.Intermediate
BREM-010--
BREM-011--
BREM-012--
BREM-013--
BREM-014--
BREM-015--
BREM-016-(S)-1-((4S,7S,10R,13S,16S)-4-amino-7-(4-(benzyloxy)benzyl)-10-(4-((2-chlorobenzyl)amino)butyl)-13-isobutyl-5,8,11,14-tetraoxo-1-phenyl-16-(3-(3-tosylguanidino)propyl)-2-oxa-6,9,12,15-tetraazaheptadecan-17-oyl)-N-(2-(methylamino)-2-oxoethyl)pyrrolidine-2-carboxamide
BREM-017--
BREM-018--
Bremelanotide189691-06-3-
OptimisedRoute 3Steps 9 · Total yield 5.0486 g
Synthetic routes & intermediates Route 3
CodeCAS No.Intermediate
BREM-010--
BREM-019--
BREM-020--
BREM-021--
BREM-022--
BREM-023--
BREM-024--
BREM-025--
BREM-026--
Bremelanotide189691-06-3-
OptimisedRoute 4Steps 9 · Total yield 6.4 g
Synthetic routes & intermediates Route 4
CodeCAS No.Intermediate
BREM-027--
BREM-028--
BREM-029--
BREM-030--
BREM-031--
BREM-032--
BREM-033--
BREM-034--
BREM-035--
Bremelanotide189691-06-3-

Also available in our peptide catalogue

Frequently asked questions

What are the approved indications of Bremelanotide?

Approved indications include: 心理性性功能障碍.

When does the Bremelanotide patent expire?

No public expiry year is available for Bremelanotide yet; this page updates once verified.

How many synthesis routes are recorded for Bremelanotide?

4 synthesis routes are recorded; the shortest is 9 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Bremelanotide intermediates?

All intermediates in Bremelanotide routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Bremelanotide intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24